This report contains market size and forecasts of Toxoplasmosis Diagnostic Testing in Global, including the following market information:
Global Toxoplasmosis Diagnostic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Toxoplasmosis Diagnostic Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Indirect Immune Fluorescent Test (IFAT) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Toxoplasmosis Diagnostic Testing include Abbott, Thermo Fisher Scientific, Bio-Rad, Danaher, Biomerica, Biotest and GenBio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Toxoplasmosis Diagnostic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Toxoplasmosis Diagnostic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Toxoplasmosis Diagnostic Testing Market Segment Percentages, by Type, 2021 (%)
Indirect Immune Fluorescent Test (IFAT)
Modified Agglutination Test (MAT)
Enzyme-Linked Immunosorbent Assay (ELISA)
Immunoglobulin Tests
Global Toxoplasmosis Diagnostic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Toxoplasmosis Diagnostic Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Diagnostic Laboratories
Others
Global Toxoplasmosis Diagnostic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Toxoplasmosis Diagnostic Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Toxoplasmosis Diagnostic Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Toxoplasmosis Diagnostic Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Thermo Fisher Scientific
Bio-Rad
Danaher
Biomerica
Biotest
GenBio